SARS-COV-2 CN2 STRAIN .BETA.-PROPIOLACTONE INACTIVATED VACCINE ANTIGEN
UNII M1QXB372B8

Substance Identification & Data

This profile provides standardized clinical and technical data for Sars-cov-2 Cn2 Strain .beta.-propiolactone Inactivated Vaccine Antigen, uniquely identified by the FDA Unique Ingredient Identifier (UNII) M1QXB372B8.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

M1QXB372B8

CAS Registry Number

N/A

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SARS-COV-2 CN2 STRAIN .BETA.-PROPIOLACTONE INACTIVATED VACCINE ANTIGEN

Official standardized name for this substance within the FDA UNII nomenclature system.

Substance Type

structurallyDiverse

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Sars-cov-2 Cn2 Strain .beta.-propiolactone Inactivated Vaccine Antigen. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.